JPMorgan Chase & Co’s Sensei Biotherapeutics SNSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $275 | Sell |
32
-3
| -9% | -$26 | ﹤0.01% | 5861 |
|
|
2025
Q1 | $276 | Hold |
35
| – | – | ﹤0.01% | 5883 |
|
|
2024
Q4 | $345 | Hold |
35
| – | – | ﹤0.01% | 5789 |
|
|
2024
Q3 | $422 | Sell |
35
-2
| -5% | -$24 | ﹤0.01% | 5750 |
|
|
2024
Q2 | $464 | Buy |
37
+4
| +12% | +$50 | ﹤0.01% | 5671 |
|
|
2024
Q1 | $701 | Hold |
33
| – | – | ﹤0.01% | 5663 |
|
|
2023
Q4 | $462 | Hold |
33
| – | – | ﹤0.01% | 5900 |
|
|
2023
Q3 | $501 | Hold |
33
| – | – | ﹤0.01% | 5769 |
|
|
2023
Q2 | $762 | Hold |
33
| – | – | ﹤0.01% | 5585 |
|
|
2023
Q1 | $1K | Hold |
33
| – | – | ﹤0.01% | 5681 |
|
|
2022
Q4 | $1K | Sell |
33
-53
| -62% | -$1.61K | ﹤0.01% | 5486 |
|
|
2022
Q3 | $3K | Buy |
86
+21
| +32% | +$733 | ﹤0.01% | 5283 |
|
|
2022
Q2 | $3K | Sell |
65
-7,753
| -99% | -$358K | ﹤0.01% | 5382 |
|
|
2022
Q1 | $361K | Sell |
7,818
-171
| -2% | -$7.9K | ﹤0.01% | 4166 |
|
|
2021
Q4 | $926K | Sell |
7,989
-478
| -6% | -$55.4K | ﹤0.01% | 3737 |
|
|
2021
Q3 | $1.78M | Sell |
8,467
-487
| -5% | -$102K | ﹤0.01% | 3248 |
|
|
2021
Q2 | $1.75M | Buy |
8,954
+1,172
| +15% | +$229K | ﹤0.01% | 3299 |
|
|
2021
Q1 | $2.26M | Buy |
+7,782
| New | +$2.26M | ﹤0.01% | 3167 |
|